Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Megan Mayer
Observed names:
Megan R Mayer,
Megan R. Mayer
Institutions:
New York State Psychiatric Institute,
Columbia University
Observed institutions:
Columbia University Irving Medical Center,
New York State Psychiatric Institute,
Stony Brook University,
Columbia University
ORCID:
0000-0002-1175-3417
Observed ORCID:
0000-0002-1175-3417
OpenAlex ID:
A5068030230
Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine
2023
·
Pejman Sehatpour
, Dan V. Iosifescu
, et al.
·
Biological Psychiatry
·
41
PDF
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia
2021
·
Anissa Abi-Dargham
, Jonathan A Javitch
, et al.
·
Schizophrenia Bulletin
·
29
PDF
Challenges and Strategies for the Recruitment of Patients With Schizophrenia in a Research Setting
2022
·
Elizabeth Deckler
, Melissa Ferland
, et al.
·
The International Journal of Neuropsychopharmacology
·
22
PDF
Effect Size Deflation With Increasing Sample Size in Adjunctive Trials for Negative Symptoms in Schizophrenia: A Meta-Analysis and Meta-Regression Across Mechanisms of Action
2025
·
Joshua T. Kantrowitz
, Megan R. Mayer
, et al.
·
American Journal of Psychiatry
·
13
Illness Phase as a Key Assessment and Intervention Window for Psychosis
2022
·
Christian G. Kohler
, Daniel H. Wolf
, et al.
·
Biological Psychiatry Global Open Science
·
10
PDF
Grant Report on D-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †
2020
·
Natalie de la Garrigue
, Juliana Glasser
, et al.
·
Journal of Psychiatry and Brain Science
·
8
PDF
Augmentation of learning in schizophrenia by d-serine and auditory remediation is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study
2023
·
Viraj Govani
, Adithya M. Shastry
, et al.
·
Schizophrenia Research
·
7
PDF
Knowing is Half the Battle: The Factors Leading to Efficient Recruitment of Representative Samples in Schizophrenia Research
2025
·
Joohyun Yoon
, Megan R. Mayer
, et al.
·
Pharmaceutical Medicine
·
6
A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial
2025
·
Clara Fonteneau
, Zailyn Tamayo
, et al.
·
Journal of Psychiatric Research
·
3
Serotonin type 3 receptor (5-HT3R) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis
2026
·
Megan R. Mayer
, Tse-Hwei Choo
, et al.
·
Neuropsychopharmacology
743. Time-Limited Exercise Combined With Olanzapine/Samidorphan Leads to Sustained Weight Attenuation in Schizophrenia: Preliminary Results
2026
·
Madison Teets
, Anne Lewandowski
, et al.
·
Biological Psychiatry
259. Investigating Feasibility and Efficacy of Implementing a Time-Limited, Fitness Smartwatch-Assisted Exercise Regimen to Enhance Weight-Attenuating Effects of Olanzapine/Samidorphan in a Population With Schizophrenia
2026
·
Anne Lewandowski
, Madison Teets
, et al.
·
Biological Psychiatry
478. Cross-Site Quality Assessment of Data From a Pharmacologic Neuroimaging Trial Targeting Working Memory Neural Circuits in Schizophrenia
2025
·
Catrin Zharyy
, Clara Fonteneau
, et al.
·
Biological Psychiatry
Recent Advances in Target Engagement Studies in Schizophrenia
2025
·
*Joshua T Kantrowitz
, Daniel Iosifescu
, et al.
·
The International Journal of Neuropsychopharmacology
PDF
415. Interest in Clinical Trials Involving Experimental Medication Among People With Schizophrenia
2024
·
Tala Berro
, Megan Mayer
, et al.
·
Biological Psychiatry
459. Reducing Errors in Clinical Trials: The Importance of Acknowledging Human Error and Improving Quality Control
2024
·
Megan Mayer
, Preetika Govil
, et al.
·
Biological Psychiatry
462. Meta-Analysis of Adjunctive Treatment Trials for Cognitive Deficits in Schizophrenia
2024
·
Shannon Peleg
, Jayda Melnitsky
, et al.
·
Biological Psychiatry
438. Meta-Regression of Adjunctive Treatment Trials for Cognitive Deficits in Schizophrenia
2024
·
Jayda Melnitsky
, Shannon Peleg
, et al.
·
Biological Psychiatry
Show more works
View as search
Works count:
18
Citation count:
139
H-index:
7
I10-index:
5
Year
Topic
Type